You are powered by which model

I'm Orris, your AI assistant! I'm not able to share information about the underlying model that powers me. If you have any questions I can help with — whether it's medical, financial, research, or anything else — just ask!

30922.jpg

Can you teach me the whole syllabus which i have uploaded because i have the exams coming this week. Teach in a way that no questions in the theory should be left and mcqs

Asking for Preferences

Reading File

Finding Sources

Here is your complete exam-focused study guide for Neurology, CVS, and Respiratory - tailored for your 6th Semester MBBS Clinical Posting exams. This is organized as theory + MCQs for every major topic.

📚 6th SEM MBBS - CLINICAL POSTING EXAM NOTES

Systems: Neurology | CVS | Respiratory

(Based on: Bradley & Daroff's Neurology, Braunwald's Heart Disease, Harrison's, Goldman-Cecil)

🧠 SECTION 1: NEUROLOGY

PART A: HISTORY TAKING IN NEUROLOGY

Components of Neurological History

Component	Key Points to Ask
Chief Complaint	Headache, weakness, numbness, seizures, speech problems, vision changes, gait disturbance, memory loss
History of Present Illness	Onset (sudden vs gradual), duration, progression, aggravating/relieving factors
Past Medical History	Hypertension, DM, cardiac disease, prior strokes, infections
Family History	Epilepsy, migraines, Huntington's, muscular dystrophy
Drug History	Anticoagulants, antiepileptics, steroids
Social History	Smoking, alcohol, occupation

Important Onset Patterns (MCQ favorite!)

Sudden onset = Stroke, subarachnoid hemorrhage
Subacute (days-weeks) = Tumor, abscess, subdural hematoma
Chronic progressive = Degenerative disease (Parkinson's, Alzheimer's)
Episodic/recurrent = Epilepsy, migraine, TIA, MS

PART B: NEUROLOGICAL EXAMINATION

Step-by-step approach

1. Higher Mental Functions (MMSE based)

Orientation (time, place, person)
Memory (immediate, recent, remote)
Attention & concentration
Language (fluency, comprehension, naming, repetition, reading, writing)
Constructional ability
Judgment and insight

2. Cranial Nerve Examination

Nerve	Test	Common Lesion
CN I (Olfactory)	Smell test each nostril	Anosmia - frontal lobe tumor, head injury
CN II (Optic)	Visual acuity, fields, fundoscopy	Papilledema (raised ICP), optic neuritis (MS)
CN III, IV, VI	Eye movements, pupil	CN III palsy - blown pupil (PCA aneurysm)
CN V (Trigeminal)	Sensation face, corneal reflex, jaw jerk	Trigeminal neuralgia
CN VII (Facial)	Forehead wrinkling, eye closure, smile	UMN (forehead spared) vs LMN (all face)
CN VIII	Hearing (whisper, Weber, Rinne)	Acoustic neuroma
CN IX, X	Gag reflex, uvula deviation	Bulbar palsy vs pseudobulbar
CN XI	Sternomastoid, trapezius strength	Accessory nerve palsy
CN XII (Hypoglossal)	Tongue protrusion	Deviation to side of lesion (LMN)

Key MCQ: In UMN VII palsy - forehead is SPARED (bilateral cortical representation). In LMN VII palsy - entire face affected including forehead.

3. Motor System Examination

Feature	UMN Lesion	LMN Lesion
Tone	Increased (spastic)	Decreased (flaccid)
Power	Decreased	Decreased
Reflexes	Exaggerated (hyperreflexia)	Diminished/absent
Plantar	Extensor (Babinski +)	Flexor (normal)
Wasting	Disuse atrophy (late)	Prominent wasting
Fasciculations	Absent	Present
Clonus	Present	Absent

4. Sensory System Examination

Superficial: Light touch, pain (pin prick), temperature
Deep: Vibration (128 Hz tuning fork), proprioception (joint position sense)
Cortical: Two-point discrimination, stereognosis, graphesthesia

5. Cerebellar Examination (DANISH mnemonic)

Dysdiadochokinesia
Ataxia (gait - broad based, reeling)
Nystagmus (to side of lesion)
Intention tremor
Scanning speech (dysarthria)
Hypotonia

6. Gait Assessment

Gait Type	Cause
Hemiplegic (circumduction)	Stroke (UMN lesion)
Scissor gait	Spastic paraplegia, CP
High stepping (footdrop)	Common peroneal nerve palsy
Waddling	Proximal muscle weakness (myopathy)
Festinating (shuffling)	Parkinson's disease
Ataxic (broad-based)	Cerebellar disease
Sensory ataxia (Romberg +)	Posterior column disease

PART C: MAJOR NEUROLOGICAL DISORDERS

1. STROKE

Definition

Sudden onset neurological deficit due to vascular cause lasting >24 hours (or any duration if imaging shows infarct).

Types

Type	Frequency	Mechanism
Ischemic	80%	Thrombotic or embolic
Hemorrhagic	20%	HTN, AVM, aneurysm
TIA	Minutes-hours	Same as ischemic but <24h, no infarct

Risk Factors (Modifiable vs Non-modifiable)

Modifiable: HTN (#1), DM, smoking, AF, hyperlipidemia, obesity
Non-modifiable: Age, sex (male), race, family history

Clinical Features by Territory

Territory	Artery	Deficits
MCA (most common)	Middle cerebral	Contralateral hemiplegia (face+arm>leg), hemisensory loss, aphasia (dominant), neglect (non-dominant)
ACA	Anterior cerebral	Contralateral leg weakness > arm
PCA	Posterior cerebral	Contralateral hemianopia, thalamic pain
Brainstem (basilar)	Basilar artery	Crossed signs (ipsilateral CN + contralateral body), locked-in syndrome
Lacunar	Small penetrating	Pure motor, pure sensory, ataxic hemiparesis, dysarthria-clumsy hand
PICA (Wallenberg)	Posterior inferior cerebellar	Ipsilateral face pain/temp loss + Horner's + ipsilateral cerebellar signs + Contralateral body pain/temp loss, dysphagia, dysarthria

Investigations

Immediate CT brain (non-contrast) - rule out hemorrhage
MRI brain (DWI) - gold standard for ischemic stroke
ECG - AF
Echo - cardiac emboli
Carotid Doppler - stenosis
CBC, RFT, LFT, PT/INR, blood glucose

Treatment

Ischemic Stroke	Hemorrhagic Stroke
IV tPA (alteplase) within 4.5 hours	Reverse anticoagulation
Aspirin 300mg (if no thrombolysis)	Control BP (target <140mmHg)
Mechanical thrombectomy (large vessel, up to 24h)	Neurosurgical consult
DVT prophylaxis	Avoid antiplatelets
Statins, antihypertensives	Osmotherapy (mannitol) for ICP

Key MCQ: Contraindications to tPA - Hemorrhage on CT, BP >185/110, recent surgery (<14 days), seizure at onset, INR >1.7, platelets <100,000.

2. EPILEPSY / SEIZURES

Classification (ILAE 2017)

Focal onset (partial): Aware (simple partial) or impaired awareness (complex partial)
Generalized onset: Tonic-clonic, absence, myoclonic, tonic, atonic, clonic
Unknown onset

Tonic-Clonic (Grand Mal) Seizure - Phases

Aura (if focal onset)
Tonic phase - rigid, apnea, cyanosis (~30 sec)
Clonic phase - rhythmic jerking (~1-2 min)
Postictal phase - confusion, headache, Todd's paresis

Common Drug Treatment

Seizure Type	First-line Drug
Focal seizures	Carbamazepine, Levetiracetam, Lamotrigine
Generalized tonic-clonic	Valproate, Levetiracetam, Lamotrigine
Absence	Ethosuximide, Valproate
Myoclonic	Valproate, Levetiracetam
Status Epilepticus	Lorazepam → Phenytoin → Phenobarbitone → General anesthesia

Key MCQ: Drug of choice for absence seizure = Ethosuximide (Valproate if generalized also). Carbamazepine WORSENS absence seizures!

3. MENINGITIS

CSF Analysis (Must Memorize!)

Parameter	Normal	Bacterial	Viral	TB	Fungal
Appearance	Clear	Turbid/purulent	Clear	Straw yellow/xanthochromic	Clear
Pressure	Normal	Raised	Normal/slightly raised	Raised	Raised
Cells	0-5 lympho	>1000 PMN	10-300 lympho	100-400 lympho	10-200 lympho
Protein	15-45 mg/dL	>100 mg/dL	Normal/slightly raised	100-500 mg/dL	Raised
Glucose	60-70% serum	<40 mg/dL (very low)	Normal	Low	Very low
Special	-	Gram stain +ve	PCR +ve	AFB/ADA raised	India ink +ve

Treatment

Bacterial: Ceftriaxone + Vancomycin (+ Dexamethasone to reduce inflammation)
Viral: Acyclovir (HSV), supportive
TB meningitis: 2HRZE + 4HR + Steroids (dexamethasone)
Cryptococcal: Amphotericin B + Flucytosine then Fluconazole

4. PARKINSON'S DISEASE

Cardinal Features (TRAP mnemonic)

Tremor - resting tremor ("pill-rolling"), 4-6 Hz, disappears with movement
Rigidity - lead pipe or cogwheel
Akinesia/Bradykinesia - slowness of movement
Postural instability - late feature, falls

Other Features

Micrographia (small handwriting)
Hypomimia (masked facies)
Festinating gait, shuffling
Autonomic dysfunction (constipation, orthostatic hypotension)
Depression (50%), dementia (30%)

Treatment

Drug	Mechanism	Notes
Levodopa + Carbidopa	DA precursor	Most effective, gold standard
Dopamine agonists (Pramipexole, Ropinirole)	DA receptor agonist	Better for younger patients
MAO-B inhibitors (Selegiline, Rasagiline)	Inhibits DA breakdown	Neuroprotective?
COMT inhibitors (Entacapone)	Prolongs levodopa	Used with levodopa
Amantadine	DA release, NMDA antagonist	Helps dyskinesias
Anticholinergics (Trihexyphenidyl)	Reduce cholinergic activity	For tremor in young

Key MCQ: Levodopa + Carbidopa (peripheral DOPA decarboxylase inhibitor) - reduces peripheral side effects, allows more L-DOPA to cross BBB.

5. HEADACHE

Type	Character	Features	Treatment
Migraine	Unilateral, pulsating, moderate-severe	Nausea/vomiting, photophobia, phonophobia; aura in 20-30%	Triptans (acute), Propranolol/Topiramate (prophylaxis)
Tension	Bilateral, band-like, pressing	No nausea, no aura	NSAIDs, amitriptyline (prophylaxis)
Cluster	Unilateral periorbital, excruciating	Autonomic features (lacrimation, rhinorrhea, Horner's), restless	O2 100% (acute), Sumatriptan; Verapamil (prophylaxis)
SAH	Sudden onset "thunderclap" worst headache	Neck stiffness, LOC	Emergency CT, then lumbar puncture

Key MCQ: "Worst headache of life" + sudden onset = Subarachnoid hemorrhage until proven otherwise. CT within 6 hours (sensitive 98%), then LP (xanthochromia).

NEUROLOGY MCQs - Practice

Q1. A patient has weakness of left face (involving forehead), left arm, and left leg. Where is the lesion? A. Right UMN lesion - Wait, forehead IS involved, so this is LMN (right facial nerve + left brain)? No - if forehead is involved = LMN CN VII palsy (right side) PLUS separate UMN lesion for arm/leg? Actually: weakness of ALL of left face including forehead + left limbs = LMN right CN VII + Right hemisphere UMN (two lesions) OR this is LMN Bell's palsy with separate cause for limbs.

Correct answer: If all left face (including forehead) + limbs affected - think Millard-Gubler syndrome (pontine lesion: ipsilateral LMN CN VII + contralateral hemiplegia).

Q2. Drug of CHOICE for absence seizures in a child:

A. Phenytoin
B. Carbamazepine
C. Ethosuximide ✅
D. Phenobarbitone

Q3. A 65-year-old man presents with sudden right-sided weakness, expressive aphasia (Broca's). Which artery is involved?

A. Right MCA
B. Left MCA ✅ (dominant hemisphere, Broca's area = left inferior frontal gyrus)
C. Left ACA
D. Left PCA

Q4. Resting tremor that disappears on intentional movement is characteristic of:

A. Cerebellar disease
B. Essential tremor
C. Parkinson's disease ✅
D. Wilson's disease

Q5. CSF showing: Turbid, high PMNs, very low glucose, high protein - diagnosis?

A. Viral meningitis
B. Bacterial meningitis ✅
C. TB meningitis
D. Fungal meningitis

Q6. The MOST immediate investigation in a patient with suspected stroke is:

A. MRI brain
B. CT brain (non-contrast) ✅
C. Carotid Doppler
D. ECG

Q7. Wallenberg syndrome involves occlusion of:

A. MCA
B. ACA
C. PICA ✅
D. Basilar artery

Q8. "Pill-rolling tremor" is seen in:

A. Cerebellar ataxia
B. Parkinson's disease ✅
C. Hyperthyroidism
D. Hepatic encephalopathy

❤️ SECTION 2: CARDIOVASCULAR SYSTEM (CVS)

PART A: CVS HISTORY TAKING

Key Symptoms to Elicit

Symptom	Clinical Significance
Chest pain	Character, radiation, onset, duration, relieving factors
Dyspnea	On exertion? At rest? Orthopnea? PND? (NYHA class)
Palpitations	Regular or irregular, rate, onset/offset, associated symptoms
Syncope/Pre-syncope	Exertional? Postural? With palpitations?
Edema	Pitting? Dependent? Diurnal variation?
Cyanosis	Central vs peripheral
Fatigue	Low cardiac output state

NYHA Classification (Must Know)

Class I: No symptoms with ordinary activity
Class II: Slight limitation - comfortable at rest, symptoms with ordinary activity
Class III: Marked limitation - comfortable at rest, symptoms with less than ordinary activity
Class IV: Symptoms at rest, inability to carry any physical activity

Chest Pain Characteristics

Type	Character	Radiation	Relief
Angina	Squeezing/pressure, substernal	Left arm, jaw, back	Nitrates, rest
MI	Same but more severe, lasting >20 min	Same	No relief with nitrates
Pericarditis	Sharp, pleuritic, worse lying flat	Shoulder	Leaning forward
Aortic dissection	Tearing/ripping, instantaneous maximum	Back	Nil
GERD	Burning, substernal	Throat	Antacids

PART B: CVS EXAMINATION

General Examination (Hands to Heart approach)

1. Hands/Peripheral

Clubbing - cyanotic CHD, infective endocarditis (IE)
Splinter hemorrhages - IE
Osler's nodes (painful, fingers) - IE
Janeway lesions (painless, palms/soles) - IE
Capillary refill >2 seconds = poor perfusion
Peripheral cyanosis

2. Pulse Assessment

Rate, rhythm, volume, character, radio-femoral delay

Pulse Character	Association
Bounding (water-hammer)	Aortic regurgitation, PDA, AVM, CO2 retention
Pulsus paradoxus (>10 mmHg drop with inspiration)	Cardiac tamponade, severe asthma
Pulsus alternans	Severe LV failure
Plateau pulse (anachrotic)	Aortic stenosis
Bisferiens	Mixed AS+AR, HOCM
Pulsus parvus et tardus	Severe AS
Collapsing pulse	Aortic regurgitation

Key MCQ: Radio-femoral delay = Coarctation of aorta.

3. JVP (Jugular Venous Pressure)

Normal <4 cm above sternal angle
Raised in: RHF, cardiac tamponade, superior vena cava obstruction, constrictive pericarditis

JVP Wave	Cause
'a' wave	Atrial contraction
Cannon 'a' waves (giant)	Complete heart block, VT, junctional rhythm (atria contract against closed tricuspid valve)
'c' wave	Tricuspid valve closure
'x' descent	Atrial relaxation
'v' wave	Passive atrial filling
Giant 'v' waves	Tricuspid regurgitation
'y' descent	Tricuspid valve opening
Absent 'y' descent (Kussmaul's sign - JVP rising with inspiration)	Constrictive pericarditis, cardiac tamponade

4. Precordial Examination

Inspection:

Visible apex beat location
Sternal pulsation (lift/heave)

Palpation:

Apex beat: Normal = 5th ICS, MCL. Displaced = cardiomegaly
Thrills: Palpable murmurs (grade 4+)
Heaves: RV heave (left parasternal) = pulmonary hypertension, RVH

Percussion:

Cardiac borders (less commonly done now)

Auscultation:

Area	Valve
Aortic area (2nd ICS RSB)	Aortic valve
Pulmonary area (2nd ICS LSB)	Pulmonary valve
Tricuspid area (lower LSB / 4th ICS)	Tricuspid valve
Mitral area (Apex)	Mitral valve

Heart Sounds

Sound	Cause	Significance
S1	Mitral + Tricuspid closure	Loud S1 in MS
S2	Aortic + Pulmonary closure	Splitting: physiological (inspiration), fixed (ASD), paradoxical (LBBB, AS)
S3 (KEN-tucky)	Rapid ventricular filling	Pathological: LV failure, dilated cardiomyopathy (normal in young <40)
S4 (Ten-NES-see)	Atrial contraction against stiff ventricle	Always pathological: hypertensive HD, hypertrophic cardiomyopathy, AS
Opening snap	Mitral valve snapping open	Mitral stenosis - closer to S2 = more severe

PART C: MAJOR CVS DISORDERS

1. HEART FAILURE

Definition

Inability of the heart to pump blood sufficient to meet metabolic demands of the body, or to do so only at elevated filling pressures.

Types

HFrEF (EF <40%) - systolic dysfunction - dilated cardiomyopathy, post-MI
HFpEF (EF ≥50%) - diastolic dysfunction - hypertension, hypertrophic CM, constrictive pericarditis

Causes

Left HF: IHD, HTN, aortic/mitral valve disease, cardiomyopathy
Right HF: Left HF (most common cause), pulmonary hypertension, COPD, PE, right-sided valve disease

Symptoms

Left HF	Right HF
Dyspnea on exertion	Ankle edema
Orthopnea	Ascites
PND	Hepatomegaly (congestive)
Cough (pink frothy)	JVP raised
Pulmonary edema

Investigations

ECG - LVH, prior MI
CXR - Cardiomegaly, pulmonary edema (ABCDE: A=alveolar edema bat wing, B=Kerley B lines, C=Cardiomegaly, D=Dilated upper lobe vessels, E=Effusion pleural)
Echo - EF, wall motion, valves
BNP/NT-proBNP - elevated (best biomarker for HF)
LFTs, RFTs, electrolytes

Treatment (HFrEF - Evidence based)

Drug Class	Drug	Benefit
ACE inhibitor / ARB	Ramipril, Enalapril	Mortality reduction - FIRST line
Beta-blocker	Carvedilol, Metoprolol, Bisoprolol	Mortality reduction
Aldosterone antagonist	Spironolactone, Eplerenone	Mortality reduction (severe HF)
SGLT2 inhibitor	Dapagliflozin, Empagliflozin	Hospitalization + mortality reduction (newest)
ARNi	Sacubitril/Valsartan	Superior to ACE-I (PARADIGM-HF)
Diuretics	Furosemide	Symptom relief (no mortality benefit)
Digoxin		Reduces hospitalizations, not mortality

Key MCQ: The "FABSNEDS" drugs for HFrEF mortality reduction: Furosemide is NOT - it only provides symptom relief! The 4 disease-modifying classes: ACEi/ARB, Beta-blockers, MRA, SGLT2i.

2. ISCHEMIC HEART DISEASE (Angina + MI)

Stable Angina

Predictable, on exertion, relieved by rest/nitrates
Treatment: Short-acting nitrate (GTN spray) for acute; Beta-blockers, Long-acting nitrates, CCBs for prevention; Aspirin + Statin

Acute Coronary Syndrome (ACS) - MUST KNOW

Feature	STEMI	NSTEMI	Unstable Angina
Pain	Severe, prolonged	Severe, prolonged	At rest, prolonged
ECG	ST elevation, LBBB	ST depression, T-inversion, normal	ST depression, T changes, normal
Troponin	Markedly elevated	Elevated	Normal
Mechanism	Complete occlusion	Partial occlusion	Partial occlusion
Treatment	Immediate PCI or Thrombolysis	Anticoagulation + early invasive	Medical ±Invasive

STEMI Territories (MCQ hot topic!)

ECG Leads	Territory	Artery
II, III, aVF	Inferior	RCA (80%) or LCx
V1-V4	Anterior	LAD
V1-V2	Septal	LAD (septal branches)
I, aVL, V5-V6	Lateral	LCx
V7-V9 (or tall R in V1-V2)	Posterior	RCA or LCx
V1-V6, I, aVL	Extensive anterior	LAD (proximal)

STEMI Management (Time = Muscle!)

Aspirin 300mg + Ticagrelor 180mg (or Clopidogrel 600mg) - DAPT
Anticoagulation - Heparin/Enoxaparin
Primary PCI within 90 min (door-to-balloon) - PREFERRED
Thrombolysis (streptokinase/tenecteplase) if PCI not available within 120 min
Oxygen only if SpO2 <90%
Morphine for pain (use carefully)
Beta-blocker (if no contraindication)
Statin (high intensity - atorvastatin 80mg)
ACE-I after stabilization

3. HYPERTENSION

Classification (JNC 8 / ACC/AHA 2017)

Category	SBP	DBP
Normal	<120	<80
Elevated	120-129	<80
Stage 1 HTN	130-139	80-89
Stage 2 HTN	≥140	≥90
Hypertensive crisis	>180	>120

Hypertensive Emergency vs Urgency

Emergency: BP >180/120 + END ORGAN DAMAGE (encephalopathy, MI, pulmonary edema, aortic dissection, retinal hemorrhage, renal failure, eclampsia)
Urgency: BP >180/120 + NO end organ damage

Treatment

HTN type	Drug of Choice
Uncomplicated HTN	ACEi/ARB, CCB, Thiazide diuretic
HTN + CKD/DM	ACEi or ARB
HTN + Heart failure	ACEi/ARB + Beta-blocker + Spironolactone
HTN + Angina	Beta-blocker or CCB
HTN + Pregnancy	Methyldopa, Labetalol, Hydralazine (ACEi/ARB CONTRAINDICATED)
Hypertensive emergency	IV Labetalol, IV Nicardipine, IV Sodium nitroprusside
Pheochromocytoma	Phenoxybenzamine (alpha-blocker FIRST, then beta)

Key MCQ: In pheochromocytoma, NEVER give beta-blocker FIRST (will cause paradoxical severe hypertension by leaving alpha receptors unopposed). Always alpha block first!

4. MITRAL STENOSIS (MS)

Cause: Rheumatic fever (most common)
Pathology: Fusion of mitral valve commissures → restricted opening

Clinical Features

Dyspnea, orthopnea, PND
Hemoptysis (pink frothy sputum or frank hemorrhage)
Palpitations (AF - very common complication)
Malar flush (butterfly rash on cheeks - in severe MS with low CO)

Examination Findings

Pulse: Low volume, irregularly irregular (if AF)
JVP: Raised (in RHF)
Apex beat: Tapping (palpable S1), not displaced
Auscultation: Loud S1, Opening Snap (OS), Mid-diastolic rumble at apex (heard best in left lateral position with bell)
S2-OS interval: Shorter = more severe MS
Graham-Steell murmur: Early diastolic murmur at pulmonary area (pulmonary regurgitation from pulmonary hypertension)

Complications

Atrial fibrillation (most common)
Left atrial thrombus → systemic emboli → stroke
Pulmonary hypertension
Eisenmenger syndrome (if severe pulmonary HTN)

Treatment

Medical: Diuretics (pulmonary congestion), Beta-blocker/Digoxin (rate control in AF), Anticoagulation (warfarin for AF or thrombus)
Interventional: Percutaneous Balloon Mitral Valvotomy (PBMV) - preferred in pliable valve without MR or thrombus
Surgical: Open mitral commissurotomy or Mitral valve replacement

5. AORTIC REGURGITATION (AR)

Causes

Acute: IE, aortic dissection, trauma
Chronic: Rheumatic fever, bicuspid AV, Marfan syndrome, ankylosing spondylitis, syphilis

Clinical Features (many eponyms!)

Sign	Description
Corrigan's pulse	Collapsing/water-hammer pulse
de Musset's sign	Head nodding with pulse
Quincke's sign	Capillary pulsation in nail bed
Duroziez's sign	Systolic + diastolic murmur over femoral artery
Traube's sign	Pistol shot over femoral artery
Hill's sign	Popliteal SBP >20mmHg above brachial SBP
Mueller's sign	Pulsation of uvula

Auscultation

Early diastolic murmur at left sternal border (3rd ICS), heard best sitting forward + breath held in expiration
Austin-Flint murmur: Mid-diastolic rumble at apex (jet of AR hitting anterior MV leaflet - mimics MS but no OS)

CVS MCQs - Practice

Q1. A 45-year-old patient with rheumatic MS develops sudden severe dyspnea with pink frothy sputum. The most likely precipitant is:

A. Pleural effusion
B. New onset AF ✅ (loss of atrial kick → pulmonary edema)
C. Pneumonia
D. Pulmonary embolism

Q2. Which drug is given FIRST in pheochromocytoma with hypertension?

A. Metoprolol
B. Amlodipine
C. Phenoxybenzamine ✅
D. Atenolol

Q3. STEMI affecting II, III, aVF leads is due to occlusion of:

A. LAD
B. LCx
C. RCA ✅
D. All three

Q4. Drug NOT recommended in HFrEF for mortality reduction is:

A. Carvedilol
B. Ramipril
C. Furosemide ✅ (symptom relief only)
D. Spironolactone

Q5. Opening snap is characteristic of:

A. Aortic stenosis
B. Mitral stenosis ✅
C. Mitral regurgitation
D. Aortic regurgitation

Q6. Fixed splitting of S2 is pathognomonic of:

A. LBBB
B. RBBB
C. Atrial Septal Defect ✅
D. Pulmonary stenosis

Q7. Which is the BEST biomarker for heart failure?

A. Troponin
B. CK-MB
C. BNP/NT-proBNP ✅
D. CRP

Q8. "Tapping apex beat" is seen in:

A. Aortic stenosis
B. Mitral stenosis ✅
C. Mitral regurgitation
D. Dilated cardiomyopathy

🫁 SECTION 3: RESPIRATORY SYSTEM

PART A: RESPIRATORY HISTORY TAKING

Key Symptoms

Symptom	Key Questions
Cough	Duration, dry or productive, character of sputum (color, amount, blood)
Dyspnea	Onset, exertion/rest, MRC grade, orthopnea (pulmonary edema, bilateral pleural effusion)
Hemoptysis	Amount, color, mixed with sputum or pure blood, associated symptoms
Wheeze	Episodic vs persistent, trigger factors
Chest pain	Pleuritic (worse on breathing) vs musculoskeletal vs cardiac
Fever	Night sweats (TB), rigors (pneumonia)

MRC Dyspnea Scale

Grade 0: Breathless only with strenuous exercise
Grade 1: Breathless when hurrying on level or walking up slight hill
Grade 2: Walks slower than people of same age, stops on level walking
Grade 3: Stops after 100m or a few minutes on level
Grade 4: Too breathless to leave house

Hemoptysis - Causes to Memorize

Common: Pulmonary TB, Bronchogenic carcinoma, Bronchiectasis, Pneumonia
Less common: PE, Goodpasture's, Mitral stenosis, AVM
Massive hemoptysis (>200ml/24h): TB most common cause

PART B: RESPIRATORY EXAMINATION

Inspection

Respiratory rate (normal 12-20/min), rhythm, depth
Chest shape: Barrel chest (COPD - AP diameter increased), Pigeon chest (pectus carinatum), Funnel chest (pectus excavatum), Kyphoscoliosis
Tracheal position
Use of accessory muscles
Intercostal retraction (obstruction)
Cyanosis

Palpation

Tracheal deviation: Away from lesion (effusion, tension pneumothorax), Toward lesion (collapse/fibrosis)
Expansion: Symmetrical or reduced on one side
Tactile vocal fremitus (TVF): Feel with ulnar edge of palm - vibration when patient says "99"
- Increased TVF: Consolidation
- Decreased/absent TVF: Effusion, pneumothorax, collapse

Percussion

Normal: Resonant
Dull: Consolidation, collapse, pleural effusion, tumor
Stony dull: Pleural effusion
Hyper-resonant: Pneumothorax, emphysema

Auscultation

Breath Sound	Cause
Vesicular (normal)	Normal lung
Bronchial breathing	Consolidation (vocal resonance increased)
Diminished/absent	Effusion, pneumothorax, collapse, obesity
Wheezes (rhonchi)	Asthma, COPD (airway narrowing)
Crepitations (crackles)	Pneumonia, pulmonary edema, fibrosis
Fine end-inspiratory crackles	Pulmonary fibrosis
Coarse crackles	Pneumonia, bronchiectasis
Pleural rub	Pleurisy (sounds like walking on fresh snow)

Summary Table of Signs

Condition	Trachea	Expansion	TVF	Percussion	BS	VR
Consolidation	Central	Reduced (affected side)	Increased	Dull	Bronchial	Increased
Pleural Effusion	Away (large)	Reduced	Absent/decreased	Stony dull	Absent	Absent
Pneumothorax	Away (tension)	Reduced	Absent	Hyper-resonant	Absent	Absent
Collapse (with obstruction)	Toward	Reduced	Absent	Dull	Absent	Absent
Fibrosis	Toward	Reduced	Increased	Dull	Bronchial	Increased
Emphysema/COPD	Central	Bilateral reduced	Reduced	Hyper-resonant	Vesicular diminished	Reduced

PART C: MAJOR RESPIRATORY DISORDERS

1. PNEUMONIA

Classification

CAP (Community Acquired): S. pneumoniae (#1), Mycoplasma, H. influenzae, Legionella
HAP (Hospital Acquired, >48h): S. aureus (MRSA), Pseudomonas, Klebsiella, E. coli
Aspiration: Anaerobes, gram negatives
Atypical pneumonia: Mycoplasma pneumoniae, Chlamydophila, Legionella (no cell wall, don't respond to beta-lactams)

Clinical Features

Fever, cough with purulent sputum
Chest pain (pleuritic)
Signs of consolidation (dull percussion, bronchial breathing, increased VR)
"Rusty sputum" = Streptococcus pneumoniae (pneumococcal)
"Currant jelly sputum" = Klebsiella
"Salmon pink sputum" = Klebsiella (lobar, right upper lobe in alcoholics/diabetics)

Severity Assessment - CURB-65 Score

Feature	Points
Confusion (new)	1
Urea >7 mmol/L	1
Respiratory rate ≥30/min	1
BP systolic <90 or diastolic ≤60	1
Age ≥65	1

Score 0-1: Low risk - outpatient
Score 2: Moderate risk - hospital admission
Score 3-5: High risk - ICU consideration

Treatment

Setting	Treatment
CAP mild (outpatient)	Amoxicillin (or Doxycycline)
CAP moderate (inpatient)	Beta-lactam + Macrolide (Amoxicillin/Ceftriaxone + Azithromycin)
CAP severe (ICU)	Beta-lactam + Macrolide OR Respiratory fluoroquinolone
Atypical pneumonia	Macrolide (Azithromycin) or Doxycycline
Legionella	Fluoroquinolone (Levofloxacin) or Macrolide
HAP/VAP	Piperacillin-tazobactam or Cefepime ± Vancomycin/Linezolid (for MRSA)

2. ASTHMA

Definition

Chronic inflammatory disease of airways with reversible airflow obstruction, airway hyperresponsiveness, and inflammation.

Precipitants (Triggers)

Allergens (dust mites, pollen, pet dander)
Respiratory infections (viral URTIs)
Exercise
Cold air, pollution
NSAIDs, Aspirin, Beta-blockers
Emotions, stress

Spirometry in Asthma

FEV1/FVC ratio <0.70 (obstructive pattern)
Reversibility: FEV1 improvement ≥12% and ≥200mL after bronchodilator = ASTHMA
Peak flow variability >20% = Asthma

Classification (Severity)

Mild intermittent: <2 days/week, normal between attacks
Mild persistent: >2 days/week but not daily
Moderate persistent: Daily symptoms
Severe persistent: Continuous symptoms, frequent exacerbations

Stepwise Treatment (GINA Guidelines)

Step	Treatment
Step 1	As-needed SABA (salbutamol) OR low-dose ICS-formoterol PRN
Step 2	Low-dose ICS + as-needed SABA
Step 3	Low-dose ICS-LABA
Step 4	Medium/high-dose ICS-LABA
Step 5	Add-on tiotropium, anti-IgE (Omalizumab), anti-IL5 (Mepolizumab)

Acute Severe Asthma - Features

Cannot complete sentences
RR >25/min, HR >110/min
PEFR 33-50% of predicted/best
Life-threatening: SpO2 <92%, PEFR <33%, silent chest, cyanosis, bradycardia, exhaustion

Acute Severe Asthma - Treatment

Oxygen (target SpO2 94-98%)
Nebulized SABA (salbutamol 2.5-5mg) - repeat every 20 min
Ipratropium bromide (add if severe)
Systemic steroids (prednisolone 40-50mg oral or IV hydrocortisone 100mg)
IV Magnesium sulfate (if life-threatening)
IV Aminophylline (if no response)
Consider ICU/intubation

Key MCQ: Drug CONTRAINDICATED in asthma: Beta-blockers (including eye drops!), NSAIDs/Aspirin (in aspirin-sensitive asthma - Samter's triad: asthma + nasal polyps + aspirin sensitivity).

3. COPD

Definition

Persistent, progressive airflow limitation not fully reversible, associated with enhanced inflammatory response in airways/lungs to noxious particles or gases (mainly tobacco smoke).

Pathology

Chronic bronchitis: "Blue bloater" - productive cough ≥3 months/year for ≥2 years, central cyanosis, hypercapnia, cor pulmonale
Emphysema: "Pink puffer" - destruction of alveolar walls, barrel chest, hyperinflation, pursed-lip breathing, weight loss

Spirometry

FEV1/FVC <0.70 (post-bronchodilator) - confirms obstruction
Severity by FEV1 (GOLD staging):
- GOLD 1 (Mild): FEV1 ≥80%
- GOLD 2 (Moderate): FEV1 50-79%
- GOLD 3 (Severe): FEV1 30-49%
- GOLD 4 (Very severe): FEV1 <30%

Treatment (Stable COPD)

Severity	Treatment
All COPD	Smoking cessation (MOST effective!), vaccines (influenza, pneumococcal)
Mild (GOLD 1-2)	SABA or SAMA as needed
Moderate-Severe	LAMA (Tiotropium) ± LABA
Very severe or exacerbations	LAMA + LABA + ICS
LTOT	If PaO2 ≤55mmHg or SaO2 ≤88% (improves survival)

Key MCQ: Only interventions that improve SURVIVAL in COPD: (1) Smoking cessation, (2) Long-term oxygen therapy (LTOT), (3) Lung volume reduction surgery (selected emphysema patients).

COPD Exacerbation

Increased dyspnea, cough, sputum (purulent = bacterial)
Causes: Viral (50%) > Bacterial (H. influenzae, S. pneumoniae, M. catarrhalis)
Treatment: Bronchodilators (nebulized SABA + SAMA), Steroids (prednisolone 30-40mg x 5 days), Antibiotics (if purulent sputum/CXR infiltrate), Controlled oxygen (target SpO2 88-92%), Consider NIV if pH <7.35

4. PULMONARY TUBERCULOSIS

Pathogenesis

Mycobacterium tuberculosis (aerobic, acid-fast bacillus)
Primary complex: Ghon focus (subpleural, lower lobe) + hilar lymphadenopathy
Latent TB: Immunity contains but cannot eliminate

Clinical Features

Constitutional: Fever (low grade, evening), night sweats, weight loss, anorexia, malaise
Respiratory: Cough >2 weeks (dry initially then productive), hemoptysis, chest pain, dyspnea

Investigations

Sputum AFB smear (Ziehl-Neelsen): rapid but less sensitive
Sputum culture (LJ medium - 6-8 weeks; MGIT - 2 weeks): gold standard
CBNAAT/GeneXpert: Rapid diagnosis + rifampicin resistance detection
CXR: Upper lobe infiltrates, cavitation, fibrosis, hilar adenopathy
TST (Mantoux): ≥10mm = positive in general population; ≥5mm in HIV/immunocompromised
IGRA (QuantiFERON-TB Gold): More specific than TST, not affected by BCG

Treatment (RNTCP/WHO - Revised)

Phase	Drugs	Duration
Intensive phase	Isoniazid + Rifampicin + Pyrazinamide + Ethambutol (2HRZE)	2 months
Continuation phase	Isoniazid + Rifampicin (4HR)	4 months
Total		6 months

Drug Side Effects (MCQ GOLD mine!)

Drug	Key Side Effect
Isoniazid (H)	Peripheral neuropathy (prevent with Pyridoxine/B6), Hepatitis, DRESS
Rifampicin (R)	Orange-colored urine/tears/sweat, Hepatitis, Drug interactions (P450 inducer)
Pyrazinamide (Z)	Hyperuricemia/Gout, Hepatitis
Ethambutol (E)	Optic neuritis (retrobulbar) - color vision loss, visual acuity
Streptomycin (S)	Ototoxicity (VIII nerve), Nephrotoxicity

5. PLEURAL EFFUSION

Transudates vs Exudates (Light's Criteria)

An effusion is an EXUDATE if ANY ONE of these is present:

Pleural fluid protein / Serum protein > 0.5
Pleural fluid LDH / Serum LDH > 0.6
Pleural fluid LDH > 2/3 of upper normal limit of serum LDH

Transudate	Exudate
Cardiac failure	Pneumonia (parapneumonic)
Nephrotic syndrome	TB
Liver cirrhosis	Malignancy
Hypoalbuminemia	Pulmonary embolism
Hypothyroidism	Mesothelioma
	Rheumatoid arthritis, SLE

Key MCQ: Pleural fluid glucose <60mg/dL (or <50% serum) = Rheumatoid arthritis, Empyema, Malignancy, TB, Lupus (RED MALE mnemonic: Rheumatoid, Empyema, Drugs, Malignancy, Adeno-TB, Lupus, Esophageal rupture)

RESPIRATORY MCQs - Practice

Q1. A 30-year-old develops shortness of breath, wheeze, and cough after visiting a friend with a cat. Spirometry shows FEV1/FVC 0.65, improving to 0.78 after bronchodilator. Diagnosis?

A. COPD
B. Asthma ✅ (reversible obstruction + trigger)
C. Bronchiectasis
D. Pulmonary fibrosis

Q2. "Currant jelly sputum" in an alcoholic patient with right upper lobe consolidation suggests:

A. Streptococcus pneumoniae
B. Mycoplasma pneumoniae
C. Klebsiella pneumoniae ✅
D. Pseudomonas aeruginosa

Q3. Drug causing OPTIC NEURITIS in TB treatment:

A. Isoniazid
B. Rifampicin
C. Pyrazinamide
D. Ethambutol ✅

Q4. Pleural fluid protein/serum protein = 0.6, pleural LDH/serum LDH = 0.7. This is:

A. Transudate
B. Exudate ✅ (both criteria met)
C. Cannot determine
D. Chylothorax

Q5. Only survival benefit in COPD is provided by (select TWO):

A. ICS
B. LABA
C. Smoking cessation ✅
D. Long-term oxygen therapy ✅
E. Theophylline

Q6. Barrel chest with hyperresonance, diminished breath sounds, and forced expiration with pursed lips. Spirometry: FEV1/FVC = 0.55. Diagnosis?

A. Asthma
B. COPD (Emphysema type) ✅
C. Pleural effusion
D. Pneumothorax

Q7. A CURB-65 score of 3 in CAP indicates:

A. Outpatient management
B. Hospital admission ward
C. ICU/High dependency care ✅
D. Home IV antibiotics

Q8. Ghon focus + hilar lymphadenopathy = ?

A. Secondary TB
B. Primary TB complex ✅
C. TB pleuritis
D. Miliary TB

Q9. Drug CONTRAINDICATED in asthma:

A. Salbutamol
B. Budesonide
C. Propranolol ✅
D. Theophylline

Q10. Which sputum color is CLASSIC for pneumococcal pneumonia?

A. Green
B. Rusty/brick red ✅
C. Currant jelly
D. Pink frothy

⚡ QUICK REVISION - MUST-KNOW TABLES

Top 10 MCQ Traps

Topic	Wrong Answer (trap)	Correct Answer
CN VII UMN vs LMN	Think forehead spared = LMN	UMN = forehead spared (bilateral supply)
Absence seizure drug	Carbamazepine	Ethosuximide
Pheochromocytoma	Beta-blocker first	Alpha-blocker first (Phenoxybenzamine)
COPD oxygen target	94-98% (like normal)	88-92% (to avoid hypoxic drive removal)
Furosemide in HF	Reduces mortality	Only symptom relief
Asthma spirometry	Non-reversible obstruction	Reversible (≥12% + ≥200mL improvement)
MS apex beat	Displaced	NOT displaced (tapping)
TB drug + optic neuritis	Isoniazid	Ethambutol
Stroke - CT first or MRI?	MRI (better)	CT FIRST (to rule out hemorrhage)
AR murmur	Heard sitting up?	Yes - early diastolic, left sternal border, leaning forward

System-wise Day-Plan for Your Remaining Days

Date	Topic	Focus
July 13 (TODAY)	Neuro History + Examination	History taking, CN exam, Motor/Sensory
July 14 (Tomorrow)	CVS History	Deep dive CVS history, chest pain, JVP, murmurs
July 15	Respiratory	History, exam signs table, asthma vs COPD
July 16	Neuro Disorders	Stroke, Epilepsy, Meningitis, Parkinson's
July 21-23	CVS Disorders	HF, ACS, HTN, valve diseases
July 27	Respi Disorders	Pneumonia, TB, Pleural effusion

Good luck with your exams! 🎯 The key areas that come up most in clinical posting exams are:

The examination technique (they will ask you to examine a patient)
Signs and their clinical significance (the tables above)
Drug of choice questions (the MCQs cover the classic ones)
Spot diagnosis from clinical description

If you want me to go deeper into any specific topic, explain a clinical case, or give more MCQs on any system - just ask!

This is a shared conversation. Sign in to Orris to start your own chat.